🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In this study, patients with soft tissue sarcoma (STS) will receive ADI-PEG...
Status
Active Not Recruiting
Location
Washington University School of Medicine
Start Date
2024-03-14
Trial ID
NCT05813327
Treatments Being Tested
To find the best dose of ADI-PEG20 that can be given in combination with ca...
Status
Recruiting
Location
MD Anderson Cancer Center
Start Date
2024-02-29
Trial ID
NCT06085729
Treatments Being Tested
Evaluate efficacy and safety of ADI-PEG 20 in patients with NASH...
Status
Recruiting
Location
Ditmanson Medical Foundation Chiayi Christian Hospital；Chiayi Christian Hospital (CYCH)
Start Date
2023-09-13
Trial ID
NCT05842512
The investigators have recently demonstrated that argininosuccinate synthas...
Status
Completed
Location
Stanford Medicine
Start Date
2018-05-09
Trial ID
NCT03449901
Treatments Being Tested
To examine whether the arginine depleting drug, ADI-PEG 20, might be effect...
Status
Unknown
Location
The Royal Sussex County Hospital
Start Date
2011-01
Trial ID
NCT01279967
Treatments Being Tested
Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM A...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2019-07-30
Trial ID
NCT03970447
This Phase I trial combines ADI-PEG 20 with docetaxel in patients with adva...
Status
Completed
Location
University of California at Davis
Start Date
2011-09-06
Trial ID
NCT01497925
Treatments Being Tested
RATIONALE: Pegylated arginine deiminase may stop the growth of tumor cells ...
Status
Completed
Location
University of Miami Sylvester Comprehensive Cancer Center - Miami
Start Date
2004-06
Trial ID
NCT00450372
Treatments Being Tested
This is an open label, intra-patient dose escalation, to evaluate ADI-PEG 2...
Status
Not Yet Recruiting
Location
University of California, San Francisco
Start Date
2026-03-09
Trial ID
NCT07389278
To compare the efficacy and safety in subjects with advanced or metastatic ...
Status
Terminated
Location
Mayo Clinic Arizona
Start Date
2023-11-29
Trial ID
NCT05712694